Stay updated with breaking news from Jonathan Heeney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cambridge University scientists’ vaccine technology provides protection against all known variants of SARSCoV-2 – the virus that causes Covid-19 and the first SARS epidemic in 2002
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants
The developers said that it 'is an exceptionally different vaccine technology - it's a real turning point.'
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals. The studies suggest that a single vaccine with combinations of these antigens – a substance that causes the immune system to produce antibodies against it – could protect against an even greater range of current and future coronaviruses.
A new 'future-proof' vaccine has shown promise in providing protection against new viruses and Covid-19 variants.